The unique silver alloy and hydrogel coating of the Bardex®IC Foley Catheters help reduce CAUTIs by more than a third1-4. This innovative technology reduces the ability of bacteria to bond to the catheter surface.
Theadvantages over conventional catheters are supported by a wide range of clinical studies.2-3, 5-6 Bardex® IC Foley Catheters have a Rapid Review Panel Level One recommendation and are available via Drug Tariff and NHS Supply Chain.
Bard and Bardex, are registered trademarks of C. R. Bard Inc. *Bacti-Guard® silver coating is licensed from Bactiguard AB. Bacti-Guard is a registered trademark of Bactiguard AB.
1. Barron D., Donegan J., and Porter D. (1998). APIC 25th Annual Educational Conference and International Mtg., 1998 San Diego, AJIC, Vol 26, No 2
2. Bologna, A, et al. (1999). Hydrogel/silver ion-coated urinary catheter reduces nosocomial infection rates in intensive care unit patients: A multicentre study. Urology. 54:982-987
3. Karchmer, T.B. et al. (2000). A randomized crossover study of silver-coated urinary catheters in hospitalised patients. Arch Intern Med, 160(21):3294-8
4. Lai, K.K. and S.A. Fontecchio. (2002). Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalised patients. Am J Infect Control. 30(4): 221-5
5. Rupp, M.E et al. (2004) Effect of silver-coated urinary catheters: efficacy, cost-effectiveness and antimicrobial resistance. Am J Infect Control;32(8):445-450
6. Newton, T et al. (2002). A comparison of the effect of early insertion of standard latex and silver-impregnated latex foley catheters on urinary tract infections in burn patients. Infect Control Hosp Epidemiol;23(4):217-218
Tilgate Forest Business Park
Customer Care: 01293 529555